Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control studyMehmet Güngör Kaya, Yat Yin Lam, Metin Özkan et al.|International Journal of Cardiology|2012Cited by 325
LBA6 PACIFIC-5: A phase III study of consolidation durvalumab (D) in patients (pts) with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy (cCRT or sCRT)Yi‐Long Wu, Lin Wang, Chung‐Li Wang et al.|Annals of Oncology|2024Cited by 8
NEBIVOLOL IN PRIMARY PREVENTION OF CHEMOTHERAPY-INDUCED CARDIOMYOPATHYMehmet Kaya, İbrahіm Özdoğru, Özgür Günebakmaz et al.|Journal of the American College of Cardiology|2010Cited by 0